Remifentanil's effect is not prolonged in a patient with pseudocholinesterase deficiency.
Manullang
J
J
Department of Anesthesiology, University of Utah, Salt Lake City 84132, USA.
Egan
T D
TD
D000328:Adult; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D002091:Butyrylcholinesterase / Q000172:deficiency*; D005260:Female; D006801:Humans; D019148:Neuromuscular Blockade; D009467:Neuromuscular Depolarizing Agents; D010880:Piperidines / Q000627:therapeutic use*; D011182:Postoperative Care; D000077208:Remifentanil; D012121:Respiration, Artificial; D013390:Succinylcholine; D013997:Time Factors
D000701:Analgesics, Opioid; D009467:Neuromuscular Depolarizing Agents; D010880:Piperidines; D002091:Butyrylcholinesterase; D013390:Succinylcholine; D000077208:Remifentanil